【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。
金融界
05-20
今日
宁德时代
(3750.HK)上市,派格生物医药-B(2565.HK)、
吉宏股份
(2603.HK)、
恒瑞医药
(1276.HK)、
MIRXES-B
(2629.HK)处于申购期。
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536655551?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-20 06:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2536655551","market":"hk","top_or_hot":-1,"title":"【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","media":"金融界","content":"<html><body><div>今日<span><a href=\"https://laohu8.com/S/300750\">宁德时代</a></span>(3750.HK)上市,派格生物医药-B(2565.HK)、<span><a href=\"https://laohu8.com/S/002803\">吉宏股份</a></span>(2603.HK)、<span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span>(1276.HK)、<a href=\"https://laohu8.com/S/02629\">MIRXES-B</a>(2629.HK)处于申购期。</div></body></html>","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-20 06:51 北京时间 <a href=https://24h.jrj.com.cn/2025/05/20065150517602.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/05/20065150517602.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2360107325.USD","symbol_name":"BGF FUTURE OF TRANSPORT \"A4\" (USD) INC","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/05/20065150517602.shtml","article_id":"2536655551","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2536655551","pubTimestamp":1747695077,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","600276":"恒瑞医药","LU2360107325.USD":"BGF FUTURE OF TRANSPORT \"A4\" (USD) INC","LU0320764755.SGD":"FTIF - Templeton Asian Growth A Acc SGD","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","LU2275660780.HKD":"SCHRODER ISF GLOBAL CLIMATE CHANGE EQUITY \"A\" (HKD) ACC","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","BK4526":"热门中概股","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU0011963245.USD":"abrdn SICAV I ASIA PACIFIC SUSTAINAB LE EQUITY \"A\" (USD) ACC","LU0132412106.USD":"abrdn SICAV I - EMERGING MARKETS EQUITY \"A\" (USD) ACC","JKS":"晶科能源","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","02603":"吉宏股份","LU0607220059.USD":"SCHRODER ISF HONG KONG EQUITY \"A\" (USD) ACC","IE00BD6J9T35.USD":"NEUBERGER BERMAN NEXT GENERATION MOBILITY \"A\" (USD) ACC","LU2399975544.HKD":"ALLIANZ ALL CHINA EQUITY \"AT\" (HKD) ACC","HSTECH":"恒生科技指数","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0029875118.USD":"TEMPLETON ASIAN GROWTH \"A\" INC","BK0224":"电气机械","LU0164872284.USD":"HSBC GIF GLOBAL EMERGING MARKETS EQUITY \"A\" (USD) ACC","02629":"MIRXES-B","HSCEI":"国企指数","YANG":"三倍做空富时中国ETF-Direxion","002803":"吉宏股份","BK0188":"融资融券","LU0228659784.USD":"施罗德金砖四国基金","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","BK0012":"证金概念","IE00B8HQ1Z84.USD":"BNY MELLON GLOBAL EMERGING MARKETS OPPORTUNITIES \"A\" (USD) ACC","03750":"宁德时代","LU1880383440.USD":"AMUNDI FUNDS CHINA EQUITY \"A2\" (USD) INC","LU0828238088.HKD":"SCHRODER ISF GLBL EMGNG MKT OPPS \"A\" (HKD) ACC","BK4519":"光伏太阳能","LU2153592121.USD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc USD","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU1961090484.USD":"ALLIANZ ALL CHINA EQUITY \"A\" (USD) INC","LU2506951792.HKD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (HKDHDG) ACC"},"translate_title":"[Hong Kong stock IPO news: Ningde Times is listed today] Ningde Times (3750. HK) is listed today, Paige Biomedicine-B (2565. HK), Jihong (2603. HK), Hengrui Medicine (1276. HK), MIRXES-B (2629. HK) is in the subscription period.","themeId":"1ea80db38c3506c20a683f9ead28ae6d","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1,"399441":1,"600276":1,"02629":1,"02603":1,"HSCEI":1,"03750":1,"HSTECH":1,"JKS":1,"YANG":1,"002803":1,"EVS.SI":0.6},"content_text":"今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536655551","isCrawlerRequest":true}
精彩评论